Accurate data as the foundation of equitable cancer control: Lessons from global cancer statistics 2024 and the complexity of ovarian cancer [0.03%]
精准数据为基础的癌症控制：来自全球2024年癌症统计数据和卵巢癌复杂性的启示
Christina R Washington,Kathleen N Moore,Isabelle L Ray-Coquard
Christina R Washington
Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries [0.03%]
2024年全球癌症统计：186个国家的34种癌症估计发病率和死亡率（GLOBOCAN）
Hyuna Sung,Adalberto M Filho,Mathieu Laversanne et al.
Hyuna Sung et al.
This article provides updated global cancer statistics for the year 2024 based on the GLOBOCAN estimates of the International Agency for Research on Cancer. The authors describe national cancer incidence and mortality by world region and th...
Daniel McFarland,Cristiane Bergerot,Pernille Bidstrup et al.
Daniel McFarland et al.
Cancer advances are not distributed equitably among many segments of the population. Specifically, individuals with serious mental illness (SMI) face compounded disparities in cancer detection, treatment, and survival. SMI, characterized by...
Extranodal natural killer/T-cell lymphoma: From fatal to curable [0.03%]
结外自然杀伤细胞/NKT细胞淋巴瘤：从致命性疾病到可以治愈的疾病
Jie Xiong,Yok-Lam Kwong,Laurence de Leval et al.
Jie Xiong et al.
Extranodal natural killer (NK)/T-cell lymphoma (ENKTCL) is one of the most aggressive non-Hodgkin lymphomas characterized by NK-cell or T-cell origins, a geographic prevalence in Asian and South American populations, and Epstein-Barr virus ...
Radiation therapy, cytogenetic prognostication, novel systemic chemotherapy, and patient perspective in an adult with choroidal melanoma [0.03%]
眼脉络膜黑色素瘤综合治疗及患者感受
Kevin Card,Rizwan Haq,John Mignano et al.
Kevin Card et al.
Systemic amyloid light-chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates [0.03%]
ANDROMEDA之外的全身性轻链淀粉样变性的诊断挑战和治疗更新
Xia Wu,Heather Landau,Jennifer E Liu et al.
Xia Wu et al.
Systemic immunoglobulin light-chain amyloidosis is a rare but life-threatening plasma cell disorder characterized by the production of misfolded monoclonal light chains that deposit as amyloid fibrils, leading to pathologic tissue remodelin...
Correction to "Integrating multimodal management and molecular profiling in a patient with BRAF V600E-positive melanoma and brain metastases" [0.03%]
“整合多模式管理和分子特征检查在BRAF V600E阳性黑色素瘤脑转移患者中的应用”一文中错误更正
Published Erratum
CA: a cancer journal for clinicians. 2026 May-Jun;76(3):e70093. DOI:10.3322/caac.70093 2026